Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Scand J Gastroenterol ; 53(6): 741-747, 2018 06.
Article in English | MEDLINE | ID: mdl-29688072

ABSTRACT

OBJECTIVES: Corticosteroids (CS) are traditionally used as part of the basal immunosuppression (IS) following liver transplantation (LT) but are known to be associated with an increased risk of new-onset diabetes mellitus (NODM), cardiovascular morbidity and mortality. The aim of this study was to retrospectively compare the incidence of transient as well as persistent NODM, rejection rate and patient- and graft survival between patients receiving steroid-based and steroid-free maintenance IS. MATERIALS AND METHODS: A total of 238 patients liver transplanted (2008-2011) with deceased donor livers were divided into two groups, one group that received steroid-based IS (tacrolimus (TAC), corticosteroids (CS), ± mycophenolate mofetil (MMF); n = 155) (2008-2011) and another group of non-autoimmune recipients that received steroid-free IS (TAC, MMF; n = 83) according to our new maintenance IS-protocol starting January 2010. The primary and secondary end-points were patient- and graft survival, rejection rates and the incidence of NODM. The median follow-up times were 1248 days and 681 days, respectively. RESULTS: The one-year patient- and graft survival in the steroid-based and steroid-free group was 92.7% and 93.3% (ns) and 87.6% and 84.9% (ns), respectively. The incidence of biopsy proven acute rejection (BPAR) was 27.7% in both groups (ns) during follow-up. The overall incidence of persistent NODM in the two groups were 16.8% and 2.9%, respectively (p < .01). CONCLUSIONS: The results show that steroid-free low-dose tacrolimus-based IS following LT is safe and decreases the incidence of NODM significantly.


Subject(s)
Diabetes Mellitus/prevention & control , Immunosuppressive Agents/administration & dosage , Liver Transplantation/adverse effects , Tacrolimus/administration & dosage , Adolescent , Adult , Aged , Female , Graft Rejection/drug therapy , Graft Survival , Humans , Immunosuppressive Agents/therapeutic use , Incidence , Kaplan-Meier Estimate , Male , Middle Aged , Mycophenolic Acid/therapeutic use , Postoperative Complications/epidemiology , Retrospective Studies , Steroids , Sweden/epidemiology , Tacrolimus/therapeutic use , Young Adult
2.
Horm Res ; 53 Suppl 1: 19-25, 2000.
Article in English | MEDLINE | ID: mdl-10895038

ABSTRACT

The data in this article are based on investigations performed in 25 children with suspected septo-optic dysplasia (SOD). There are many signs and methods that help in the diagnosis of SOD. In particular, the ocular fundus, abnormalities of the hypothalamo-pituitary axis and other midline brain structures should be described. In order to achieve a more holistic and functional diagnosis, the degree of neurological, neuropsychiatric and psychological involvement should also be stated. It has been suggested that SOD is associated with autosomal recessive inheritance, and it can be speculated that it is the result of genetic and environmental influences early in gestation. An early diagnosis can favourably influence the outcome of the affected child.


Subject(s)
Diagnosis , Optic Nerve/abnormalities , Septum Pellucidum/abnormalities , Blindness , Child , Child, Preschool , Female , Growth Disorders/etiology , Humans , Infant , Infant, Newborn , Magnetic Resonance Imaging , Male , Nervous System Diseases/etiology , Optic Nerve/embryology , Optic Nerve/pathology , Pituitary Hormones/deficiency , Septum Pellucidum/embryology , Syndrome
3.
Am J Infect Control ; 23(5): 306-9, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8585642

ABSTRACT

BACKGROUND: Mupirocin ointment has been shown to be effective in eradicating Staphylococcus aureus nasal carriage in residents of a long-term care facility. Antiseptic soaps have been used as adjunct to this therapy. We compared the efficacy of short-term intranasal mupirocin ointment with and without chlorhexidine baths in the eradication of S. aureus nasal carriage with follow-up for 12 weeks. METHODS: Residents in four nursing homes known to have endemic methicillin-resistant S. aureus were screened for nasal carriage of S. aureus. Residents who had anterior nares cultures positive for S. aureus on two separate occasions were divided into two groups. Both groups received intranasal mupirocin ointment twice daily for 5 days and one group also received chlorhexidine baths for the first 3 days. Cultures of anterior nares, axilla, and groins were performed before treatment and 1 day and 1, 4, 8, and 12 weeks after treatment. RESULTS: After treatment, S. aureus nasal carriage was eradicated in all residents. Recolonization with S. aureus had occurred at 12 weeks in 24% of residents receiving mupirocin ointment alone (6/25) and in 15% of residents receiving mupirocin ointment plus chlorhexidine baths (4/27). CONCLUSIONS: A short course of mupirocin ointment was effective in eradicating nasal carriage of S. aureus in nursing home residents. There were no statistical differences in efficacy between the two regimens with respect to the eradication of nasal carriage and prevention of recolonization with S. aureus.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents, Local/therapeutic use , Carrier State/drug therapy , Chlorhexidine/therapeutic use , Cross Infection/drug therapy , Mupirocin/therapeutic use , Staphylococcal Infections/drug therapy , Administration, Intranasal , Administration, Topical , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/administration & dosage , Anti-Infective Agents, Local/administration & dosage , Carrier State/prevention & control , Chlorhexidine/administration & dosage , Cross Infection/prevention & control , Drug Therapy, Combination , Female , Humans , Male , Methicillin Resistance , Middle Aged , Mupirocin/administration & dosage , Nasal Cavity/drug effects , Nasal Cavity/microbiology , Nursing Homes , Staphylococcal Infections/prevention & control , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...